Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02541864|
Recruitment Status : Completed
First Posted : September 4, 2015
Results First Posted : August 10, 2017
Last Update Posted : November 24, 2017
Kaohsiung Veterans General Hospital.
Information provided by (Responsible Party):
Feng-Woei Tsay, Kaohsiung Veterans General Hospital.
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Helicobacter Pylori Infection
Drug: Bismuth quadruple therapy
Drug: Hybrid therapy
The trial was performed in a single country